Search

everythinglearnresearchcommunity

for

Search:↓

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

No treatment fully prevents hair loss from chemotherapy yet.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Where a rhesus macaque used to live can affect its chances of getting alopecia later in life, and females are more likely to be affected than males.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

AGA linked to worse COVID-19 outcomes in men.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Men with early hair loss have lower vitamin D levels.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Finasteride for hair loss may cause painless bleeding in urine and semen.

Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.

Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.

Alopecia from CDK 4/6 inhibitors worsens quality of life in breast cancer patients.

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.